# The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

> **NCT02473809** · PHASE4 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 60 (actual)

## Conditions studied

- Diabetes Complications
- Osteoporosis

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02473809
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02473809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02473809, "The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02473809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*